Javier Aranda

Gemcitabine and docetaxel for high‐risk non‐muscle‐invasive bladder cancer: <scp>EuroGemDoce</scp> group results

Pietro Scilipoti, Mattia Longoni, Mario de Angelis et al. · British Journal of Urology · 2025 · 18 citations · Full text

Medicine, Oncology, Urology +13

Assessment of a Coated Mitomycin-Releasing Biodegradable Ureteral Stent as an Adjuvant Therapy in Upper Urothelial Carcinoma: A Comparative In Vitro Study

Federico Soria, Salvador D. Aznar‐Cervantes, Julia E. de la Cruz et al. · Polymers · 2022 · 15 citations · Full text

Medicine, Bioengineering, Urology +15

Long-term Oncological Outcomes for Patients with Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin (BCG): A Comparative Analysis of Adequate Versus Inadequate BCG Treatment

Pietro Scilipoti, Mattia Longoni, Mario de Angelis et al. · European Urology Focus · 2025 · 15 citations · Full text

Medicine, Oncology, Urology +12

Animal model assessment of a new design for a coated mitomycin-eluting biodegradable ureteral stent for intracavitary instillation as an adjuvant therapy in upper urothelial carcinoma

Federico Soria, Julia E. de la Cruz, Salvador D. Aznar‐Cervantes et al. · Minerva Urology and Nephrology · 2023 · 13 citations · Full text

Medicine, Pharmacology, Urology +14

Outcomes of <scp>BCG</scp> vs upfront radical cystectomy for high‐risk non‐muscle‐invasive bladder cancer

Pietro Scilipoti, Mattia Longoni, Mario de Angelis et al. · British Journal of Urology · 2025 · 12 citations · Full text

Medicine, Oncology, Surgery +15